ARTICLE | Company News
Domain Therapeutics, Prestwick Chemical S.A.S., Institute of Genetics and Molecular and Cellular Biology neurology news
March 19, 2012 7:00 AM UTC
The ATHOS consortium, led by Domain, received €5.1 million ($6.7 million) from the French government to develop products targeting orphan GPCRs to treat schizophrenia. Domain, which received €933,000 ...